Study of D3L-002 in Subjects With Advanced Solid Tumors
NCT07667842
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumor
Interventions
DRUG:
D3L-002
Sponsor
D3 Bio (Wuxi) Co., Ltd